12972365

Source:http://linkedlifedata.com/resource/pubmed/id/12972365

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0043210, umls-concept:C0087111, umls-concept:C0242793, umls-concept:C0746922, umls-concept:C1446409, umls-concept:C1706163, umls-concept:C2697524, umls-concept:C2700445
pubmed:issue	5
pubmed:dateCreated	2003-9-15
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7502030
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0305-7372
pubmed:author	pubmed-author:DangChauC, pubmed-author:SeidmanAndrew DAD
pubmed:issnType	Print
pubmed:volume	29
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	453-6
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12972365-Adult, pubmed-meshheading:12972365-Aged, pubmed-meshheading:12972365-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12972365-Breast Neoplasms, pubmed-meshheading:12972365-Chemotherapy, Adjuvant, pubmed-meshheading:12972365-Cyclophosphamide, pubmed-meshheading:12972365-Disease-Free Survival, pubmed-meshheading:12972365-Dose-Response Relationship, Drug, pubmed-meshheading:12972365-Doxorubicin, pubmed-meshheading:12972365-Drug Administration Schedule, pubmed-meshheading:12972365-Female, pubmed-meshheading:12972365-Humans, pubmed-meshheading:12972365-Lymph Nodes, pubmed-meshheading:12972365-Mastectomy, pubmed-meshheading:12972365-Maximum Tolerated Dose, pubmed-meshheading:12972365-Middle Aged, pubmed-meshheading:12972365-Neoplasm Invasiveness, pubmed-meshheading:12972365-Neoplasm Staging, pubmed-meshheading:12972365-Paclitaxel, pubmed-meshheading:12972365-Prognosis, pubmed-meshheading:12972365-Randomized Controlled Trials as Topic, pubmed-meshheading:12972365-Survival Rate, pubmed-meshheading:12972365-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	Dose-dense treatment prolongs disease-free survival of women with node positive breast cancer.
pubmed:affiliation	Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, Newyork, NY, USA.
pubmed:publicationType	Journal Article